Eagle Health Investments’s IQVIA IQV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-121,895
Closed -$25.8M 27
2024
Q2
$25.8M Hold
121,895
4.52% 9
2024
Q1
$30.8M Sell
121,895
-51,700
-30% -$12.1M 5.73% 7
2023
Q4
$40.2M Sell
173,595
-32,500
-16% -$6.67M 8.16% 4
2023
Q3
$40.5M Sell
206,095
-13,400
-6% -$2.91M 8.93% 3
2023
Q2
$49.3M Sell
219,495
-7,000
-3% -$1.41M 9.22% 1
2023
Q1
$45M Buy
226,495
+22,400
+11% +$4.79M 8.77% 2
2022
Q4
$41.8M Buy
204,095
+4,200
+2% +$852K 9.65% 1
2022
Q3
$36.2M Buy
199,895
+73,800
+59% +$16.2M 8.31% 2
2022
Q2
$27.4M Buy
126,095
+14,100
+13% +$3.06M 6.38% 4
2022
Q1
$25.9M Buy
111,995
+12,418
+12% +$2.94M 6.38% 5
2021
Q4
$28.1M Buy
99,577
+18,400
+23% +$4.77M 6.85% 4
2021
Q3
$19.4M Sell
81,177
-4,100
-5% -$1.03M 6.17% 3
2021
Q2
$20.7M Sell
85,277
-14,900
-15% -$3.44M 7.09% 3
2021
Q1
$19.3M Buy
100,177
+27,800
+38% +$5.22M 7.59% 1
2020
Q4
$13M Buy
+72,377
New +$12.2M 8.29% 1

Other funds holding IQV

Eagle Health Investments's IQV Position: Q3 2024 in Review

Eagle Health Investments sold out of IQVIA (IQV) in Q3 2024, closing a stake of 121,895 shares — an estimated $25.8M sold.

Eagle Health Investments first reported a position in IQV in Q4 2020 and held it in 15 quarters. The position peaked at $49.3M in Q2 2023. 1,061 funds tracked by Wall St. Rank hold IQV as of Q3 2024.

  • Eagle Health Investments reported no remaining IQVIA position as of Q3 2024 after selling out during the quarter.
  • Eagle Health Investments sold 121,895 IQVIA shares in Q3 2024, an estimated $25.8M.
  • Eagle Health Investments first reported a position in IQVIA in Q4 2020 and held it in 15 quarters.
  • Eagle Health Investments's IQVIA position peaked at $49.3M in Q2 2023.
  • 1,061 funds tracked by Wall St. Rank held IQVIA as of Q3 2024.

Based on Eagle Health Investments's 13F filing for Q3 2024, filed 12 Nov 2024.